FLT3 and acute myeloid leukemia: In the present study we have investigated the frequency and impact of IDH mutations on outcome according to the different clinical risk groups, normal/aberrant cytogenetics, and also according to the FLT3 and NMP1 mutation status in 189 unselected AML patients.